Literature DB >> 20528574

Role of glutathione in cell nucleus.

Jelena Markovic1, José Luís García-Gimenez, Amparo Gimeno, José Viña, Federico V Pallardó.   

Abstract

Cells with high proliferation rate have high glutathione levels. This typical feature of cancer cells is viewed usually as a defence mechanism against ionizing radiation or chemotherapy. Efforts have been made in order to decrease cellular glutathione levels in tumours as a necessary pre-treatment for cancer therapy. However, very few reports have considered cellular glutathione as a physiological tool for cells to proliferate and that most of this high glutathione levels were located in the nucleus. The role of nuclear glutathione in cell physiology has become more important in the last years. This review summarizes new findings that point to the nuclear reduced status as an environment that induces heterochromatin formation. Glutathionylation and oxidation of nuclear proteins appear as a reversible physiological mechanism able to regulate DNA compaction, cell cycle and DNA repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528574     DOI: 10.3109/10715762.2010.485989

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  19 in total

1.  Defects in a new class of sulfate/anion transporter link sulfur acclimation responses to intracellular glutathione levels and cell cycle control.

Authors:  Su-Chiung Fang; Chin-Lin Chung; Chun-Han Chen; Cristina Lopez-Paz; James G Umen
Journal:  Plant Physiol       Date:  2014-10-31       Impact factor: 8.340

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

Review 4.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  Histone h3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure.

Authors:  José Luis García-Giménez; Gloria Òlaso; Sandra B Hake; Clemens Bönisch; Sonja M Wiedemann; Jelena Markovic; Francisco Dasí; Amparo Gimeno; Carme Pérez-Quilis; Oscar Palacios; Mercè Capdevila; José Viña; Federico V Pallardó
Journal:  Antioxid Redox Signal       Date:  2013-05-21       Impact factor: 8.401

Review 6.  Reversible and irreversible protein glutathionylation: biological and clinical aspects.

Authors:  Arthur Jl Cooper; John T Pinto; Patrick S Callery
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-05-11       Impact factor: 4.481

Review 7.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 8.  Sink into the Epigenome: Histones as Repositories That Influence Cellular Metabolism.

Authors:  Cunqi Ye; Benjamin P Tu
Journal:  Trends Endocrinol Metab       Date:  2018-07-11       Impact factor: 12.015

9.  Protein glutathionylation in cellular compartments: a constitutive redox signal.

Authors:  Stefania Petrini; Chiara Passarelli; Anna Pastore; Giulia Tozzi; Marianna Coccetti; Manuela Colucci; Marzia Bianchi; Rosalba Carrozzo; Enrico Bertini; Fiorella Piemonte
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

10.  Cellular redox imbalance and changes of protein S-glutathionylation patterns are associated with senescence induced by oncogenic H-ras.

Authors:  Tatiana Armeni; Luisa Ercolani; Lorena Urbanelli; Alessandro Magini; Francesca Magherini; Armanda Pugnaloni; Francesco Piva; Alessandra Modesti; Carla Emiliani; Giovanni Principato
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.